In a population based study of the prevalence of Wilson's disease in the Republic of Ireland from 1970-89, 26 definite and probable cases were ascertained. The adjusted birth incidence rate was 17-0 per million live births (95% (confidence interval 9*9 to 27.2)) for the 20 year period 1950-69. The gene frequency was 0-41% (95% (confidence interval 0-31% to 0-52%) indicating that one in 122 of the population was a gene carrier. Allowing for a maximal degree of consanguinity, the gene frequency is reduced to 0-36% and the proportion of heterozygotes to one in 139 of the population. The consistency of the adjusted birth incidence rates over the decades 1950-59 and 1960-69 suggests a high degree of ascertainment of diagnosed cases of Wilson's disease.
the gene frequency is reduced to 0-36% and the proportion of heterozygotes to one in 139 of the population. The 1971, 1979, 1981 and 1986 . 'True prevalence'10 was also calculated using the same denominator but using the numerator as the number of patients alive with Wilson's disease on the census day plus the number of people alive who were subsequently diagnosed as having the illness.
Although ascertainment of cases was as complete as possible, crude birth incidence figures (number of cases born in a period divided by the total births in the period) underestimate the true incidence. We have used the term birth incidence to denote this quantity, as is standard in genetic applications.'4 The measure refers to the proportion of births with the particular genetic condition, even though identification of these individuals is not made at birth. Some epidemiologists prefer the term birth prevalence. '5 Because some affected individuals remained asymptomatic and undetected by the end of the study ascertainment period of 1989, a birth incidence rate adjusted for the probability of detection was calculated. Crude and adjusted birth incidence were estimated for the two decades 1950-69. The age-specific probability of detection of a case of Wilson's disease was based on the age of diagnosis of the 12 detected cases born before 1955 as inclusion of later cases would seriously overestimate the probabilities. An adjusted number of cases born in each year from 1950-69 was obtained by dividing the observed number by the appropriate probability of detection. For example, there were three cases born in 1960, and these would have been aged 29 at the end of the study period in 1989. By age 29, according to our estimates, 75% of all cases would be detected so that the adjusted number of cases is four (3/0-75).
Confidence intervals for the adjusted birth incidence were based on a Poisson distribution for the number of observed births, with. the confidence limits multiplied by the percentage increase between the observed and adjusted births. Gene frequencies (q) were calculated from the adjusted birth incidences (1) using the Hardy-Weinberg law'6 (q2 = I), and the proportion of heterozygotes was estimated as 2q. Confidence intervals were obtained by applying these formulas to the confidence limits for the birth incidences. The Hardy-Weinberg law assumes a randomly mating population, that is, without consanguinity. Consanguinity is probably low in Ireland but estimates of the minimum possible gene frequency and the proportion of heterozygotes in the population were calculated using the highest population coefficient of inbreeding (F = 0001) likely to hold for any western European population.'4 16 The gene frequency (q) was calculated from I = q2 + Fq, and the proportion of heterozygotes as (1 -F)2q. 27.2). Using the Hardy-Weinberg law, this corresponds to a gene frequency of 0-41% (95% CI: 0-31 to 0.52) and a proportion of heterozygotes in the population of 0-82% (95% CI: 0-62 to 1-04). This means that 1 in 122 of the population carries the gene. These figures may be somewhat inflated because random mating is assumed, and allowing for a maximal likely degree of consanguinity, probably much too high for Ireland, the gene frequency reduces to 0-36% and the proportion of heterozygotes to 0-72% (1 in 139 of the population). On the basis of our data, these must be considered as the lowest possible figures for this country.
Results

CASES
included. Crude and adjusted birth incidence figures per million population were 1950-59: crude 16-1; adjusted 17-6 (95% CI: 8-4
CLINICAL AND FAMILIAL ASPECTS
Other than familial cases, there was no particular clustering by geographical distribution. The main system involved at onset was hepatic, 54%, neurological or neuropsychiatric 27%, purely psychiatric 12%, haematological 7%. Screening of siblings and parents had been performed in 13 of the 15 index case families; in two families screening was refused and we are not aware of any symptoms of disease in these two families. Eleven secondary cases had been determined at screening, six of these being confirmed by clinical investigation, five (secondary probable) cases on the basis of previous death of a sibling and in one case a paternal uncle, from an illness consistent with Wilson's disease. None of the families contained a first cousin parental marriage, but in one family the great-grandparents were first cousins. The ratio of cases to total sibling numbers was 26%, consistent with autosomal recessive inheritance. Although attempted in some families, cousin screening was not adequately performed in any family.
Discussion
Although prevalence figures are of limited use in Wilson's disease because of the high mortality due to disease severity and delayed diagnosis, it may be useful to compare the present findings to other European studies. Bachmann in East Germany reported a prevalence of [4] [5] [6] per million for a prevalence day in 19748 and Przuntek in West Germany found a prevalence rate of 2-7 per million for a prevalence day in 1975.13 Thus our prevalence rate of [3] [4] [5] [6] per million (1986) lies midway between these two. Clearly if all cases were effectively diagnosed and treated, prevalence should approach the adjusted birth incidence of 17-0 per million over the period 1950-69. Reilly We are grateful for the advice of Dr Geoffrey Dean in the planning of this study and thank all the Physicians who provided information about patients under their care.
